Informed consent before starting GLP-1 treatment

Agree what the prescription is for

Start with the benefit you expect in your own case. Is the main aim better glucose control, lower weight-related risk, easier daily movement or a mix? Ask what evidence applies to people like you and how your clinician will judge whether treatment is helping.

A balanced talk includes uncertainty. Average trial results are not a promise. A medicine can work well without matching the biggest results advertised online. Your prescriber should explain what would lead to continuing, changing or stopping treatment. Agree these points early, so later reviews rest on a shared plan.

Get the risks in plain words

Other medicines and life plans belong in the talk. Contraception, pregnancy, breastfeeding, planned procedures, diabetes treatment and medicines affected by vomiting may all matter. You do not need to know in advance which detail counts. Give an accurate list, and the clinician will judge what matters.

Compare alternatives and the work involved

Alternatives include another medicine, structured lifestyle support, a specialist referral, surgery where suitable, or not starting medicine now. Compare the likely benefits, the downsides and the effort each option asks of you. Headline weight-loss percentages tell only part of the story.

For private care, ask about the price of later doses, reviews, cancellation, continuity and support. For NHS care, ask which service will prescribe and what happens after discharge or if the pathway changes. Money and logistics affect whether you can keep going, so raise them as clinical questions.

Explain the plan back in your own words

End by explaining the plan back in your own words. Say which product you will use, when and how to take it, which changes mean you should get in touch and when your review is due. This tests how clearly the plan was explained. You are not the one being examined.

You can ask for more time, an interpreter, accessible information or a written summary. You can also change your mind. If your clinician proposes an off-label approach, ask directly for the reason and the monitoring plan. A sound decision is one you understand and make freely, with a clear way to get help when questions come up later.

Consent continues after the first prescription

Revisit consent when a major part of treatment changes. A new medicine, an off-label plan or a significant new risk may need a fresh explanation, even after a thorough first consultation. Ask what has changed and whether the alternatives have changed too.

Keep the latest written plan. A welcome email from months ago will be out of date. Understanding stays part of your care, most of all when treatment runs across different providers or stages of life.